Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

导出原文传递

翻译打印收藏纠错

作者： Gudesblatt, Mark ^[1] ; Wissemann, Karl ^[2] ; Zarif, Myassar ^[3] ; Bumstead, Barbara ; Fafard, Lori ; Wilken, Jeffrey ; Blitz, Karen ; Buhse, Marijean ; Santra, Sourav ; Hotermans, Christophe ; Lee, Lily

作者单位： South Shore Neurol Associates, Patchogue, NY USA ^[1] Washington Neuropsychol Res Grp LLC, Fairfax, VA USA ^[2] Biogen, 225 Binney St, Cambridge, MA 02142 USA ^[3]

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

CNS drugs

2018年32卷12期

1173-1181页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

CNS drugs

相似文献

CNS drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

CNS drugs

相似文献

CNS drugs

相关期刊

检索历史清除